We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0QSS Phaxiam Therapeutics

0.00 (0.0%)
01 Dec 2023 - Closed
Delayed by 15 minutes

Phaxiam Therapeutics Financial Summary

The current 0QSS market cap is 2.2B. The company's latest EPS is EUR -0.0074 and P/E is -572.97.

Year End 31 December 2022 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 4.45M5.28M3.72M4.18M6.65M
Operating Income -43.62M-64M-68.83M-56.52M-27.15M
Net Income -38.22M-62.66M-73.3M-53.8M-228k
Year End 31 December 2022 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 167.84M118.55M80.4M66.77M45.81M
Total Liabilities 22.24M32.99M53.86M43.92M22.32M
Total Equity 145.6M85.56M26.54M22.85M23.49M

Cash Flow

Year End 31 December 2022 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating -39.27M-43.31M-51.72M-56.77M-31.76M
Investing -15.04M-19.84M-1.48M-345k38.13M
Financing -818k39k25.45M44.71M-1.77M
Market Cap 2.2B
Price to Earnings Ratio -572.97
Price to Sales Ratio 19.77
Price to Cash Ratio 3.39
Price to Book Ratio 5.59
Dividend Yield -

Share Statistics

Shares Outstanding 30.99M
Average Volume (1 week) 9
Average Volume (1 Month) 10
52 Week Change 0.0%
52 Week High 71.025
52 Week Low 71.025
Spread (Intraday) 0.36 (4.88%)

Company Info

Company Name Phaxiam Therapeutics
Address 60 avenue rockefeller
lyon, rhone 69008
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |